PTC (NASDAQ:PTC) CAO Alice Christenson Sells 816 Shares

PTC Inc. (NASDAQ:PTC) CAO Alice Christenson sold 816 shares of the company’s stock in a transaction that occurred on Tuesday, May 12th. The stock was sold at an average price of $145.82, for a total value of $118,989.12. Following the transaction, the chief accounting officer owned 1,265 shares of the company’s stock, valued at approximately $184,462.30. This trade represents a 39.21% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link.

PTC Stock Down 1.2%

Shares of PTC stock opened at $144.22 on Wednesday. PTC Inc. has a 12 month low of $130.89 and a 12 month high of $219.69. The firm has a market cap of $16.66 billion, a PE ratio of 13.76, a price-to-earnings-growth ratio of 2.21 and a beta of 0.98. The stock has a 50 day moving average of $145.67 and a 200-day moving average of $162.36. The company has a quick ratio of 1.23, a current ratio of 1.23 and a debt-to-equity ratio of 0.30.

PTC (NASDAQ:PTC) last issued its quarterly earnings results on Wednesday, May 6th. The technology company reported $2.69 EPS for the quarter, topping analysts’ consensus estimates of $2.06 by $0.63. The company had revenue of $774.30 million during the quarter, compared to analyst estimates of $712.40 million. PTC had a return on equity of 25.84% and a net margin of 41.81%.The company’s quarterly revenue was up 21.7% compared to the same quarter last year. During the same period in the previous year, the company earned $1.79 earnings per share. PTC has set its FY 2026 guidance at 6.650-8.900 EPS and its Q3 2026 guidance at 1.240-1.780 EPS. On average, equities analysts predict that PTC Inc. will post 6.13 EPS for the current year.

Analysts Set New Price Targets

PTC has been the subject of several recent analyst reports. Stifel Nicolaus set a $180.00 price objective on PTC in a research note on Thursday, February 5th. Wall Street Zen upgraded PTC from a “hold” rating to a “buy” rating in a report on Saturday, April 18th. KeyCorp decreased their target price on PTC from $210.00 to $195.00 and set an “overweight” rating on the stock in a report on Tuesday, March 17th. Weiss Ratings cut PTC from a “hold (c)” rating to a “hold (c-)” rating in a report on Wednesday, May 6th. Finally, Barclays increased their target price on PTC from $180.00 to $185.00 and gave the stock an “overweight” rating in a report on Thursday, May 7th. Ten investment analysts have rated the stock with a Buy rating, five have issued a Hold rating and one has given a Sell rating to the company’s stock. According to MarketBeat.com, PTC presently has a consensus rating of “Moderate Buy” and an average target price of $177.23.

Hedge Funds Weigh In On PTC

Hedge funds have recently added to or reduced their stakes in the company. Root Financial Partners LLC bought a new position in PTC in the third quarter valued at about $30,000. Elyxium Wealth LLC bought a new position in PTC in the fourth quarter valued at about $27,000. Palladiem LLC bought a new position in PTC in the fourth quarter valued at about $28,000. DV Equities LLC bought a new position in PTC in the fourth quarter valued at about $29,000. Finally, Versant Capital Management Inc boosted its holdings in PTC by 37.6% in the third quarter. Versant Capital Management Inc now owns 194 shares of the technology company’s stock valued at $39,000 after acquiring an additional 53 shares during the last quarter. Institutional investors own 95.14% of the company’s stock.

PTC News Summary

Here are the key news stories impacting PTC this week:

• Positive Sentiment: PTC announced a new Onshape integration with Altium that should improve ECAD-MCAD collaboration, reduce file-based workflow friction, and strengthen its cloud-native design platform offering. PTC Onshape Introduces Direct Altium Integration to Streamline ECAD-MCAD Collaboration
• Positive Sentiment: Analysts raised PTC’s price target to $155, reinforcing confidence in the company’s software growth and earnings outlook. PTC (NASDAQ:PTC) Price Target Raised to $155.00
• Positive Sentiment: PTC’s reputation as a key industrial software provider and its exposure to smart factories may be helping keep longer-term investor interest intact. PTC Inc. (PTC) Inc Touted As A Firm That’s At The Heart Of America’s Industrial Revolution
• Neutral Sentiment: A PTC executive commented on the importance of a coherent ALM-PLM toolchain for autonomous vehicles, which underscores the company’s product relevance but does not appear to be a direct catalyst. Coherent ALM-PLM toolchain crucial to prepare for autonomous vehicles: PTC’s Michele Del Mondo
• Neutral Sentiment: PTC disclosed a short interest update showing no meaningful change in short positioning, offering little immediate trading impact. PTC short interest update
• Negative Sentiment: Chief Accounting Officer Alice Christenson sold 816 shares, a disclosure that can sometimes weigh on sentiment even though the dollar amount was modest. PTC insider sale Form 4
• Positive Sentiment: PTC also benefited from the announcement that Novartis paid $1 billion upfront for a Huntington’s drug tied to PTC, highlighting value in its biotech-related assets. Novartis pays $1bn upfront for Huntington’s drug from PTC

PTC Company Profile

PTC Inc (NASDAQ: PTC) is a global technology company that develops software and services to help manufacturers design, operate, and service physical products. Founded in 1985 as Parametric Technology Corporation, PTC pioneered parametric, feature-based CAD with its Pro/ENGINEER product (now marketed as Creo) and has since expanded its portfolio to address product lifecycle management, Internet of Things (IoT), augmented reality (AR) and industrial connectivity.

Key product lines include Creo for 3D CAD; Windchill for product lifecycle management (PLM); ThingWorx, an IoT platform for connecting devices and building industrial applications; Vuforia, an AR platform for creating immersive service and training experiences; and Kepware, a suite for industrial connectivity and protocol translation.